DoMore Diagnostics, a company specializing in deep learning precision diagnostic for digital pathology, and Proscia, a provider of digital and computational pathology solutions, have partnered to help pathologists predict outcomes for colorectal cancer (CRC) patients. The collaboration paves the way for integrating artificial intelligence (AI)-powered clinical decision support into routine pathology workflows, unlocking new insights…

Patient-centered innovation has been and always will be at the core of Siemens Healthineers, whose employees constantly bring breakthrough innovations to market to help healthcare professionals deliver high-quality care and achieve the best possible outcome for patients worldwide. The Siemens Healthineers Intelligent Emergency Imaging workflow powered by myExam Companion helps speed up the care pathway…

LumaFlo, a technology company developing highly potent and cost-effective air decontamination systems, announces a breakthrough solution that uses a proprietary modified carbon-based nanostructured material that can be applied to ordinary surfaces, and — in the presence of daylight or LED light — inactivates bacteria or pathogens spread by air. Air filters and ultraviolet light are…

Lawrence Berkeley National Laboratory’s MirroRx is a biomarker technology that accurately predicts disease status. The disease phenotype is analyzed by measuring how the patient’s endogenous molecules vibrate upon exposure to infrared light. The difference between the vibrational profiles of disease and control samples is so visible that the spectral process is like “cellular fingerprinting.” Aggressive…

Two towering JEOL Electron Microscopes stand ready to produce terabytes of valuable data for researchers at Generate:Biomedicines each day, who are accelerating drug discovery and development of novel therapeutics using machine learning and generative artificial intelligence. The two Transmission Electron Microscopes, the JEOL CRYO ARM 200 and CRYO ARM 300 are used in structural biology,…

Genomenon Inc., a Genomic Intelligence company, announces it has acquired Boston Genetics, a genomics interpretation and curation company. By combining Genomenon’s unrivaled AI-powered platform for genomic knowledge and tech-enabled scientific expertise with Boston Genetics’ substantial team of genetic scientists, Genomenon is now in the lead position to be the first company to curate the entire…

BBy, a healthtech company revolutionizing hospitals’ breast milk storage and administration process, introduces its food device that condenses breast milk to a powder, maintaining the crucial bioactive components that make breast milk the best infant nutrition. BBy is disrupting a 70-year-old process in which hospitals have stored and administered donor breast milk in freezers, wasting…

Thermo Fisher Scientific has opened a new sterile drug facility in Singapore that will better enable customers to deliver new medicines and vaccines in the Asia-Pacific market. The new facility also marks a significant milestone and investment in pandemic preparedness for Singapore, which is fast emerging as a biomedical hub in the Asia-Pacific region. Established…

RotaChrom has announced its rCPC platform conforms to Current Good Manufacturing Practices (cGMP) for the pharmaceutical industry, allowing the use of its rCPC purification and separation systems within cGMP-compliant laboratory and manufacturing environments. ”The GMP rCPC is a preparative purification platform that we specifically designed for the highly regulated pharmaceutical GMP environment,” said Andras Gaspar,…

Proscia, a provider of digital and computational pathology solutions, has announced that Virscio, a provider of translational research and development services, has deployed Concentriq for Research. The contract research organization (CRO) is leveraging Proscia’s flagship software platform to provide faster, more informed drug safety insights, helping its sponsors to improve research and development (R&D) efficiency.…

Elsevier, a global information analytics company, has launched EmBiology, a research tool that visualizes a comprehensive landscape of biological relationships, empowering researchers to gain a rapid understanding of disease biology and focus on critical evidence. Powered by Elsevier’s Biology Knowledge Graph, EmBiology draws on a broad and deep database of multiple sources, including over 7.2…

Bio-Rad Laboratories, a company specializing in life science research and clinical diagnostic products, is accelerating measurable residual disease (MRD) research through more than a half dozen collaborations with institutions and companies leveraging its new QX600 Droplet Digital PCR System. Launched late last year, it boasts six color detectors capable of quantifying 12 targets per well,…

Thermo Fisher Scientific and the University of California, San Francisco (UCSF), will accelerate advanced cell therapies for difficult-to-treat conditions, including cancer, rare diseases, and other illnesses, from a newly opened cGMP manufacturing facility adjacent to UCSF Medical Center’s Mission Bay campus. The partnership between Thermo Fisher and UCSF, first announced in 2021, has the potential to demonstrate…

Proscia, a provider of digital and computational pathology solutions, has strengthened its position in the $12 billion[1] preclinical R&D market. At the center of its expansion, the company is enhancing its flagship Concentriq for Research, trusted by 14 of the top 20 pharmaceutical companies as a singular software platform for pathology workflows and data, to…

Applied Biosystems has introduced the TaqMan 2.5X Lyo-Ready 1-step qPCR Master Mix with an excipient, an optimized, ready-to-use formulation to be incorporated into a lyophilization process. All lots are functionally tested to help ensure lot-to-lot reproducibility. This reagent is manufactured in an ISO 13485-certified facility to a high level of quality standards. Lyophilization guidelines provided…

Proscia, a provider of digital and computational pathology solutions, has achieved new milestones that strengthen its leadership position in the life sciences market. The company now counts 14 of the top 20 pharmaceutical companies among its users. This growth comes as Proscia continues to help users realize the full promise of their pathology data with…

By Marwan Alsarraj, BioPharma Segment Manager, Digital Biology Group As of 2021, there were 8.8 million scientists worldwide, and all their research generates data. The number of scientists continues to rise, too, resulting from the analytical-minded wanting to help the world counteract crises like the Covid-19 pandemic and climate change. The adage would claim that…

As part of its efforts to support emerging biotechnology companies with addressing key challenges of bringing new therapies to market, Thermo Fisher Scientific announces it has become a founding sponsor of Momentum Labs in Alachua, Florida. Momentum Labs will serve as a collaborative laboratory and office space for growing biotech businesses in the greater Gainesville…

Biognosys AG and Bruker Corporation announce a strategic partnership in which Bruker has made a majority-ownership investment in Biognosys. Financial details were not disclosed. J.P.Morgan acted as exclusive financial advisor to Biognosys. Several of Biognosys’ earlier investors have sold their shares to Bruker in a secondary transaction, and Bruker will make new primary investments in…

Generis, creator of the cloud data content, and business process management platform CARA, announced that Merz has selected the CARA Life Sciences platform for managing all the documents in their R&D process. Merz, headquartered in Frankfurt, Germany is a global, family-owned company represented in over 90 countries with more than 110 years of experience and…

By Jim Ross, President & CTO, Axion Biosystems The ability to study human physiology often relies on biological models but recapitulating human development and disease comprehensively in a laboratory is a challenge. Most in vitro models rely on two-dimensional systems, which offer valuable insight into how cells function in healthy and diseased states but don’t…

ViroStat has just released its new catalog of infectious disease antibodies and antigens. This newest release includes 790 antibodies for use in antigen detection assays such as lateral flow rapid tests, ELISA, IFA, and CLIA. Many recommended pairs are available. Infectious targets include viruses, bacteria, toxins, parasites, and fungi. Go to the ViroStat website www.virostat-inc.com…

By Christian Olsen, Business Segment Lead, Dotmatics Biologic drugs have increasingly delivered treatments for cancer and rare diseases and continue to prove effective in other wide-ranging areas, from neurological and metabolic disorders to respiratory and cardiovascular diseases. But along with the incredible potential biologics offer, there is also great pressure to discover and deliver novel…

Thermo Fisher Scientific Inc. has unveiled the Gibco CTS DynaCellect Magnetic Separation System (DynaCellect) to help cell therapy developers easily move from process and clinical development to commercial manufacturing. This next-generation cell isolation, cell activation, cell depletion, and Dynabeads magnetic beads removal instrument provides a scalable, flexible, automated, and closed system to help optimize the…

Thermo Fisher Scientific Inc. has opened its largest single-use technology manufacturing site in Greater Nashville. The $105 million, 400,000-ft2 facility enables the company to help meet rapidly growing demand for the bioprocessing materials needed to produce vaccines and breakthrough therapies for cancer and other diseases. This new site is part of Thermo Fisher’s $650 million…